Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Kyu-pyo Kim"'
Autor:
Jae Yun Jung, Hyun Jin Ryu, Seung-Hwan Lee, Dong-Young Kim, Myung Ji Kim, Eun Ji Lee, Yeon-Mi Ryu, Sang-Yeob Kim, Kyu-Pyo Kim, Eun Young Choi, Hyung Jun Ahn, Suhwan Chang
Publikováno v:
Cells, Vol 10, Iss 10, p 2734 (2021)
Pancreatic cancer is characterized by late detection, frequent drug resistance, and a highly metastatic nature, leading to poor prognosis. Antibody-based immunotherapy showed limited success for pancreatic cancer, partly owing to the low delivery rat
Externí odkaz:
https://doaj.org/article/82d23eafc789421396a56d1cad893624
Autor:
Woohyung Lee, Yejong Park, Jae Woo Kwon, Eunsung Jun, Ki Byung Song, Jae Hoon Lee, Dae Wook Hwang, Changhoon Yoo, Kyu-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Baek-Yeol Ryoo, Seo Young Park, Song Cheol Kim
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 5, p 1477 (2020)
Background: The association between optimal carbohydrate antigen (CA) 19-9 concentration after neoadjuvant chemotherapy (NACT) and prognosis has not been confirmed in patients with borderline resectable (BRPC) and locally advanced pancreatic cancer (
Externí odkaz:
https://doaj.org/article/ca924b5982d541078b930bf8a1609b24
Autor:
Changhoon Yoo, Sang Hyun Shin, Kyu-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Jun Ho Kang, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Jin-hong Park, Dae Wook Hwang, Ki Byung Song, Jae Hoon Lee, Baek-Yeol Ryoo, Song Cheol Kim
Publikováno v:
Cancers, Vol 11, Iss 3, p 278 (2019)
The clinical benefit and potential risks of conversion surgery after neoadjuvant chemotherapy (NACT) have not been fully investigated in patients with borderline resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer
Externí odkaz:
https://doaj.org/article/389355a030104bb884e59c74a3577bf0
Autor:
Dong-Hoon Lim, Hyunseok Yoon, Kyu-pyo Kim, Baek-Yeol Ryoo, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dae Wook Hwang, Jae Hoon Lee, Ki Byung Song, Song Cheol Kim, Seung-Mo Hong, Jaewon Hyung, Changhoon Yoo
Publikováno v:
Cancer Research & Treatment; Oct2023, Vol. 55 Issue 4, p1313-1320, 8p
Autor:
Jwa Hoon Kim, Changhoon Yoo, Seyoung Seo, Jae Ho Jeong, Baek-Yeol Ryoo, Kyu-pyo Kim, Jung Bok Lee, Keun-Wook Lee, Ji-Won Kim, Il-Hwan Kim, Myoungjoo Kang, Hyewon Ryu, Jaekyung Cheon, Sook Ryun Park
Publikováno v:
Cancers; Volume 14; Issue 3; Pages: 559
Cancers, Vol 14, Iss 559, p 559 (2022)
Cancers, Vol 14, Iss 559, p 559 (2022)
Background: We evaluated the safety and efficacy of direct oral anticoagulants (DOACs) versus subcutaneous dalteparin for cancer-associated venous thromboembolism (CA-VTE) in patients with advanced upper gastrointestinal (GI) tract, hepatobiliary, or
Autor:
Song Cheol Kim, Changhoon Yoo, Kyu-Pyo Kim, Hyoung Jung Kim, Jae Ho Byun, Ji Hun Kang, Jong Keon Jang, Dong Wan Seo, Moon-Gyu Lee, Seung Soo Lee, Jung Hee Son, Seung-Mo Hong, Jin Hee Kim
Publikováno v:
European Radiology. 31:813-823
We aimed to assess the ability of CT-determined resectability, as defined by a recent version of NCCN criteria, and associated CT findings to predict margin-negative (R0) resection in patients with PDAC after neoadjuvant FOLFIRINOX chemotherapy. Sixt
Autor:
Eun Ji Lee, Seunghwan Lee, Eun-Young Choi, Dong-Young Kim, Kyu-Pyo Kim, Yeon-Mi Ryu, Sang-Yeob Kim, Jaeyun Jung, Hyung Jun Ahn, Hyun Jin Ryu, Myung Ji Kim, Suhwan Chang
Publikováno v:
Cells, Vol 10, Iss 2734, p 2734 (2021)
Cells
Volume 10
Issue 10
Cells
Volume 10
Issue 10
Pancreatic cancer is characterized by late detection, frequent drug resistance, and a highly metastatic nature, leading to poor prognosis. Antibody-based immunotherapy showed limited success for pancreatic cancer, partly owing to the low delivery rat
Autor:
Hans Rabl, Ken Ichi Okada, Matthew H.G. Katz, Bassel F. El-Rayes, Stefan Buettner, Song Cheol Kim, Niek A. Peters, Mary Dillhoff, Christoph Tinchon, Sing Yu Moorcraft, Andrew H. Ko, Eran van Veldhuisen, Khurum Khan, Geertjan van Tienhoven, Bas Groot Koerkamp, Jill Lacy, Alessandro Paniccia, Sunhee S. Kim, Marjolein Y.V. Homs, Philippe Bachellier, Colin J. McKay, Parag J. Parikh, Pietro Addeo, Jessica M. Frakes, Andrea Wang-Gillam, Stephen Clarke, Mustafa Suker, Matthew J. Weiss, Marc G. Besselink, Ammar A. Javed, Quisette P. Janssen, Berend R. Beumer, Peter J. Hosein, Nathan Bahary, Eric A. Mellon, Ian Chau, Casper H.J. van Eijck, Martin D. McCarter, Kyu Pyo Kim, Nigel B. Jamieson, Georgios A. Margonis, Derek Grose, Johanna W. Wilmink, Maria Antonietta Bali, Hiroki Yamaue, Tanios Bekaii-Saab, Jaswinder S. Samra, Brian A. Boone
Publikováno v:
Journal of the National Cancer Institute, 111(8), 782-794. Oxford University Press
Journal of the National Cancer Institute, 111(8):djz073, 782-794. Oxford University Press
J Natl Cancer Inst
Journal of the National Cancer Institute, 111(8):djz073, 782-794. Oxford University Press
J Natl Cancer Inst
Background FOLFIRINOX is a standard treatment for metastatic pancreatic cancer patients. The effectiveness of neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer (BRPC) remains debated. Methods We performed a systematic re
Autor:
Jae Ho Jeong, Kyu-Pyo Kim, Inhwan Hwang, Changhoon Yoo, Heung-Moon Chang, Jihoon Kang, Hei Nga Natalie Ip, Baek-Yeol Ryoo
Publikováno v:
Investigational New Drugs. 37:584-590
Background Nab-paclitaxel plus gemcitabine (AG) is standard first-line chemotherapy for patients with metastatic pancreatic cancer (mPC). However, prognostic factors for patients with mPC treated with AG, are largely unknown. We retrospectively ident
Autor:
Sang Soo Lee, Kyu-Pyo Kim, Baek-Yeol Ryoo, Changhoon Yoo, Seung-Mo Hong, Dong Wan Seo, Dae Wook Hwang, Hosub Park, Su Jin Shin, Song Cheol Kim, Jin-Hong Park, You-Na Sung
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Pancreatic cancer associated double primary tumors are rare and their clinicopathologic characteristics are not well elucidated. Materials and methods Clinicopathologic factors of 1,352 primary pancreatic cancers with or without associated do